Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Investment Type: Venture Capital
Mentions in press and media 8
| Date | Title | Description |
| 13.02.2025 | New Blood in Innovation: Frank Yin Joins Washington Research Foundation | In the bustling world of innovation, fresh talent can spark a revolution. Frank Yin, Ph.D., is the latest addition to the Washington Research Foundation (WRF) as an investment associate. His mission? To unearth and nurture startup opportuni... |
| 13.02.2025 | Frank Yin joins Washington Research Foundation staff as investment associate | Washington Research Foundation Yin's role will primarily focus on identifying and evaluating startup investment opportunities to advance Washington state innovations for public benefit SEATTLE, Feb. 13, 2025 /PRNewswire-PRWeb/ -- Frank Yin,... |
| 13.01.2025 | Timberlyne: $180 Million (Series A) Raised To Develop Novel Therapies For Autoimmune Disorders | Timberlyne Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for autoimmune disorders, announced the closing of a $180 million Series A financing to advance CM313, a potentially best-in-c... |
| 10.05.2021 | Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases | SHANGHAI, May 10, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chroni... |
| 26.07.2016 | Gates Foundation leads $14M funding round for Just Biotherapeutics to battle infectious diseases | Just Biotherapeutics CEO and Founding Partner Jim Thomas Seattle-based Just Biotherapeutics said Monday it closed a $14 million funding round led by the Bill & Melinda Gates Foundation. A group of former Amgen scientists founded Just in... |
| 06.01.2016 | Daily funding roundup - January 6, 2016 | Flatiron Health bagged $175M; NextCure, Inc. raised $67M; AirCloset received $8M funding Ossia, a Bellevue, WA-based maker of a wireless power technology, received a strategic investment from Molex, LLC, a global manufacturer of electronic ... |
| 29.10.2015 | MabSpace Biosciences Completes $15M Series A Financing | MabSpace Biosciences Co., Ltd., a Suzhou, China-based company focused on the discovery and development of antibody-based therapeutics, completed a $15m Series A financing. Lilly Asia Ventures was the sole investor for the round. Led by Dr. ... |
| 21.09.2015 | Daily funding roundup - September 21, 2015 | Deciphera bagged $75M; Portea raised $37.5M; Just Biotherapeutics secured $15M BidFlyer, an Israeli startup that is a white-label platform for airlines, has raised $1 million in funding for its business model, which involves putting small b... |